GBA Presents: THE GREEN MARKET

I own a ton of Orasure Van.

Get Ready To Peddle! One of The bio's I gave you is going to go nuts today. Your welcome!

Bicycle Therapeutics price target raised to $65 from $39 at H.C. Wainwright 06:11 BCYC H.C. Wainwright analyst Swayampakula Ramakanth raised the firm's price target on Bicycle Therapeutics to $65 from $39 and reiterates a Buy rating on the shares. BT5228 yesterday "scored in both urothelial and ovarian cancers," Ramakanth tells investors in a research note. The analyst says Bicycle provided a positive clinical update from two ongoing Phase 1/2 studies of BT5528 and BT8009. The results not only show early efficacy signals for both BT5528 and BT8009, but also validate the bicycle toxin conjugates platform's therapeutic potential as a cancer therapy, says Ramakanth.

The Bicycle is old news. It was halted yesterday Stoney, I got in at $42 after the halt and dumped it at $48.
You need that software of yours to scan for trading halts dummy.
That news came out at lunchtime yesterday.
:rolleyes:
 
Why did you buy after the close if the news came out at lunch-? I wish you had told me during the day we could of created a great gummy for the folks not involved.
 
Back
Top